UBS
http://www.ubs.com/UBS provides a range of financial services, including advisory services, underwriting, financing, market making, asset management, brokerage and retail banking on a global level. The Company consists of four divisions: Wealth Management, Asset Management, Investment Banking & Security and Swiss Retail & Corporate Banking. Wealth Management offers high net worth customers advice and investment services, Asset Management offers management solutions for most types of asset class to a range of clients, Investment Banking & Security provides securities, products and research in various areas equities and Swiss Retail & Corporate Banking offers banking and securities services for Swiss clients.
-
-
-
-
-
-
-
Valeant Pharma (VRX) CEO Papa Plans to Present at Upcoming UBS Conference
-
-
-
-
-
-
-
Valeant Pharma (VRX) said to schedule non-deal roadshow at UBS on Feb. 29 - Bloomberg
-
-
-
-
-
-
-
Pre-Open Stock Movers 10/26: (PNY) (QUNR) (PBY) Higher; (AKS) (VRX) (AXP) Lower (more...)
-
-
-
-
-
-
-
Notable Mergers and Acquisitions of the Day 10/27: (WPZ)/(ACMP) (VRX)/(AGN) (HES) (CQB)
-
-
-
-
-
-
-
UBS Maintains a 'Buy' on Valeant Pharmaceuticals (VRX); Deal Supports Thesis; Stock Move Justified
-
-
-
-
-
-
-
UBS maintains a 'Buy' on Valeant Pharmaceuticals (VRX); Increasing PT for CEPH Deal
-
-
-
-
-
-
-
Notable Analyst Rating Changes 06/22: VRX, LNCR, MAT, ARBA Upgraded; BVF, BIG, WAG, NOV Downgraded
-
169,660 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

